Insights

• “Patent Eligibility of Method Claims: What Is the Impact of the Supreme Court’s Prometheus Decision?” Industrial Biotechnology (June 2012)
• “Strategies for expediting examination of US patent applications,” Industrial Biotechnology(October 2011)
• “Isolated, purified, covalent bonds, or magic microscopes? What defines patentable nucleic acid molecules?” Industrial Biotechnology (June 2011)
• “The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector,” Industrial Biotechnology (April 2012)
• “Current Views on Obviousness Under US Patent Law,” Industrial Biotechnology (October 2010)
• “‘Best Mode’ Requirements Under US Patent Law: When Your Best Description is Just Not Good Enough,” Industrial Biotechnology (August 2010)
• “After In re Kubin, can the manner in which an invention was made render the invention ‘inherently obvious?” Industrial Biotechnology (June 2009)
• “Maximizing IP value in an economic downturn (& beyond) in the life science industry,” Industrial Biotechnology (March 2009)
• “Do’s and Don’ts for Maximizing Your IP Value in Uncertain Times,” (December 2008)
• “BENCH TO BENCH: USPTO’s security & energy reviews, Pitfalls and practice tips to help prevent loss of patent rights,” Industrial Biotechnology (June 2008)
• “For better or for worse? How US legislative patent reform may affect the biotech sector,” Industrial Biotechnology (March 2008)
• “Issues in Identifying Contributors to Inventions Under U.S. Law,” AUTM Technology Transfer Practice Manual, Volume 3, Part 2, Chapter 5 (January 2008)
• “Beyond KSR v. Teleflex: How the courts and USPTO have decided biotechnology and chemistry cases,” Industrial Biotechnology (October 2007)
• “What the US Supreme Court’s KSR v. Teleflex decision means for biotech,” Industrial Biotechnology (June 2007)
• “Intellectual Property (IP) Do’s and Don’ts for Start-Up Companies,” (March 2007)
• “Do’s and Don’ts for Keeping Lab Notebooks,” com (May 1999)

Speaking engagements

• "Navigating the Patent Maze - Insights From Attorney Peter Fasse," Delta: HealthTech Innovators (January 22, 2024)
• "Everything a Startup Needs to Know About IP," Boston Entrepreneurs’ Network (January 23, 2024)
• “Entrepreneurs: What NOT To Do in Trademarks, Patents, and Trade Secrets,” Boston Entrepreneurs’ Network (February 21, 2023)
• “Bringing University Research to Market: An IP Perspective,” Boston Entrepreneurs’ Network (May 2020)
• “The Section 101 Landscape,” IP Counsel Breakfast at Flagship Pioneering(December 2019)
• “IP Do’s and Dont’s for Startups,” Presentation to Boston Entrepreneurs’ Network(December 2019)
• “2018 Life Sciences Year in Review,” Boston Seminar Series(January 2019)
• ​​”The ‘Muddy Metaphysics’ of Inventorship: What You Need to Know,” ​(June 2016)
• “Patent Eligible Subject Matter” Partners Healthcare (May 2016)
• “Patents – Just the Basics,” The Massachusetts Eye & Ear Infirmary and The Schepens Eye Research Institute (March 2016)
• “Biotech & Pharmaceutical Patent Cases: 2015 Year in Review” (January 2016)
• “Is My Project Patentable? (And What Does that Really Mean?),” Boston Children’s Hospital(June 2015)
• “Nature-Based Products and Abstract Ideas under Recent PTO Guidance and Court Decisions – Is There New Hope under Section 101?” Illumina’s Patent Department (February 2015)
• “Patent Cases at the Supreme Court and Federal Circuit: Significant Cases in 2013,” University of Massachusetts Commercial Ventures and Intellectual Property Case Managers’ Meeting(January 2014)
• “Recent Changes in US Patent Law,” Mass Eye & Ear Infirmary and the Office of Intellectual Property & Commercial Ventures (July 2013)
• “Changes in US and European Patent Law: What YOU need to Know,” University of Massachusetts Commercial Ventures and Intellectual Property Case Managers Meeting(February 2013)
• The “America Invents Act”: What You Need to Know, University of Massachusetts Commercial Ventures and Intellectual Property Case Managers Meeting (October 2011)
• The “America Invents Act”: What You Need to Know, Boston Breakfast Seminar Series(September 2011)
• “Biotech and Pharmaceutical Patents at the Federal Circuit: 2010 Year in Review,” Seminar on biotech and pharmaceutical IP law topics (January 2011)
• “2010 Patent Law Update,” Seminar for University of Massachusetts Technology Transfer Office(April 13, 2010)
• “Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets,” Munich, Germany (February 2009)
• “Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets,” Munich, Germany (January 2008)
• “Beyond KSR: What is Obvious Today?” Massachusetts Association of Technology Transfer Offices seminar (January 2008)
• “Current Trends in Investing in the Very Small,” 3rd Annual Nanotech and Microtech Investors Forum (December 2007)
• “Do’s and Don’ts for Biotech Startups,” BIO 2007 (May 2007)
• “Going Green: Ins and Outs of Growing a Green Start Up,” 2007 World Congress on Industrial Biotechnology and Bioprocessing (March 2007)
• “Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets,” Munich, Germany (January 2007)
• “The Application of Tiny Technologies to Real Products – An Industry Perspective,” 2nd Annual Nanotech Investors Forum (December 2006)
• “Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets,” Munich, Germany (December 2005)
• “What You Need To Know About Nanotechnology,” Advanced Legal Studies Course at Suffolk University Law School, Boston, Massachusetts (October 2004)

Media mentions

• Interview, “Patents in His Blood,” Angel Invest Boston Podcast (March 2017)